Delivery Order SPE2DE24D0013-SPE2D626F6722
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $1,417.52 on October 22, 2025, by the Defense Logistics Agency Medical Supply Chain under a firm fixed-price contract structure. The delivery order, designated XPRSMVP-10, is scheduled for completion by October 29, 2025, with performance occurring at Cepheid's Sunnyvale facility. This award was made without a set-aside designation, reflecting Cepheid's...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $3,740 on October 26, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and carries no set-aside designation. This delivery order represents a continuation of Cepheid's extensive federal...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,968.80 by the Defense Logistics Agency's Medical Supply Chain on April 23, 2025, with an ultimate completion date of May 7, 2025. This delivery order, which carries no set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic equipment and testing solutions to federal healthcare systems. The contract is likely...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,039.40 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025, with a completion deadline of November 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at the contractor's Sunnyvale location. The award falls under the Defense Logistics Agency's procurement operations, which...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,236 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on October 29, 2025, with an ultimate completion date of November 13, 2025. The contract, designated as XPCOV2/FLU/RSV-10, is for molecular diagnostic testing supplies and reagents, likely including test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. No...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,040 on October 23, 2025, by the Defense Logistics Agency Medical Supply Chain. The award, designated as contract number 4569817308 for XPCOV2/FLU/RSV-10 products, utilizes a firm fixed-price delivery order structure with no set-aside designation and carries an ultimate completion date of October 30, 2025. This delivery order represents work performed at...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F6722Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting relationship with the Defense Logistics Agency, which has issued numerous delivery orders for diagnostic testing supplies, test kits, and reagents to support federal healthcare operations. Cepheid has established itself as a primary federal supplier of molecular diagnostic solutions across multiple government agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's core competencies encompass the GeneXpert diagnostic platform and associated testing capabilities for infectious diseases such as COVID-19, influenza, tuberculosis, and other respiratory pathogens. The company holds two significant Indefinite Delivery Contracts with the Veterans Affairs system valued at approximately $6.7 million and $32.8 million respectively, demonstrating substantial federal procurement reliance on Cepheid's diagnostic capabilities through 2029 and 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/29/25 |